Pneumococcal Polysaccharide Conjugate Vaccine IP

Trade Name: Synflorix
Available Strength : 0.5 ML
Available Combination : SYNFLORIX contains polysaccharide derived from 10 Streptococcus pneumoniae serotypes. Each 0.5 mL dose of SYNFLORIX contains 1 microgram of Pneumococcal polysaccharide serotypes 1, 5, 6B, 7F, 9V, 14 and 23F and 3 micrograms of Pneumococcal polysaccharide serotypes 4, 18C and 19F.
Packing : 1x0.5ml
Pack Insert/Leaflet : YES
Therapeutic use : Pneumococcal polysaccharide conjugate vaccine using Protein D as the. main carrier protein. Protein D is a highly conserved surface protein from Non-Typeable. Haemophilus influenzae (NTHi).
Capacity : 1000

Additional Information

The most common markets for this product include the following countries. Please inquire with us if your country or region is not listed:

Asia: Afghanistan, Israel, Jordan, Pakistan, Russia, Saudi Arabia, Singapore, Syria, Philippines, Turkey, Turkmenistan, Uzbekistan, Yemen, Vietnam, Indonesia, Malaysia, Iran, Tajikistan, etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Africa: South Africa, Uganda, Nigeria, Ghana, Kenya, Mauritius, Botswana, Egypt, Ethiopia, Libya, Sudan, Congo, Gambia, Ivory Coast , etc.

Europe: Austria , Azerbaijan, Belarus, Belgium, Cyprus, Czech Republic, Denmark, France, Georgia, Germany, Hungary, Ireland, Iceland, Netherlands, Norway, Poland, Spain, Sweden, Switzerland, Ukraine, United Kingdom (UK) , Latvia, etc.

OCEANIA: Australia, New Zealand, Fiji, etc.